Kelly Angelle
Neurology with Special Qualifications in Child Neurology · New Orleans, LANPI 1033678271
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in LA, where the typical reported total is $5,367.
Across 123 payments — averaging $27.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$614
- Neurelis, Inc.$537
- UCB, Inc.$330
- Sarepta Therapeutics, Inc.$249
- SK Life Science, Inc.$196
- Biogen$141
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,33598%
- Education$772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 18 | $614 |
| Neurelis, Inc. | 15 | $537 |
| UCB, Inc. | 11 | $330 |
| Sarepta Therapeutics, Inc. | 12 | $249 |
| SK Life Science, Inc. | 5 | $196 |
| Biogen | 6 | $141 |
| AstraZeneca(2 entities) | 4 | $123 |
| Immedica Pharma US, Inc. | 4 | $92 |
| Acadia Pharmaceuticals Inc | 4 | $89 |
| Azurity Pharmaceuticals, Inc. | 4 | $84 |
| NS Pharma, Inc. | 3 | $80 |
| Amgen | 4 | $79 |
| AbbVie | 4 | $77 |
| Teva Pharmaceuticals USA, Inc. | 2 | $74 |
| Upsher-smith Laboratories LLC | 3 | $73 |
| Supernus Pharmaceuticals, Inc. | 3 | $69 |
| Catalyst Pharmaceuticals, Inc. | 2 | $60 |
| Sanofi | 2 | $53 |
| Biomarin Pharmaceutical Inc. | 3 | $47 |
| Argenx US, Inc. | 1 | $44 |
| Novartis | 1 | $42 |
| EMD Serono, Inc. | 2 | $39 |
| PTC Therapeutics, Inc. | 2 | $38 |
| Genentech USA, Inc. | 2 | $37 |
| ITF Therapeutics LLC | 1 | $29 |
| Aucta Pharmaceuticals, Inc. | 1 | $27 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $27 |
| Merck | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,412 in reported general payments places this provider in the 45th percentile of 30 neurology with special qualifications in child neurology providers in Louisiana.
See all neurology with special qualifications in child neurology providers in Louisiana →
Other neurology with special qualifications in child neurology in New Orleans
- Ann Henderson TiltonNew Orleans$119K
- Joaquin WongNew Orleans$28K
- Allison ConraveyNew Orleans$15K
- David HoughtonNew Orleans$9K
- Jeremy TolerNew Orleans$9K
- Jessica GautreauxNew Orleans$9K
- Daniella MillerNew Orleans$8K
- Maria WeimerNew Orleans$6K
- Rashmi RaoNew Orleans$5K
- Kayla PenceNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.